BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19667333)

  • 21. Immunophenotype and possible origin of nevi with phenotypical heterogeneity.
    Winnepenninckx V; van den Oord JJ
    Arch Dermatol Res; 2004 Jul; 296(2):49-53. PubMed ID: 15141316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of p53 in conjunctival melanocytic nevi. An immunohistochemical study.
    Jay V; Ho M; Hunter W; Rootman D; Zielenska M
    Arch Pathol Lab Med; 1996 Apr; 120(4):378-9. PubMed ID: 8619750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Melan-A in Spitz, pigmented spindle cell nevi, and congenital nevi: comparative immunohistochemical study.
    Evans MJ; Sanders DS; Grant JH; Blessing K
    Pediatr Dev Pathol; 2000; 3(1):36-9. PubMed ID: 10644168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of minichromosome maintenance 2, Ki-67, and geminin in oral nevi and melanoma.
    de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; de Almeida OP
    Ann Diagn Pathol; 2013 Feb; 17(1):32-6. PubMed ID: 22652151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
    Nielsen PS; Riber-Hansen R; Steiniche T
    Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric conjunctival melanoma arising from a compound nevus.
    Liu KC; Mruthyunjaya P; Proia AD; Vora GK
    J AAPOS; 2017 Oct; 21(5):416-418. PubMed ID: 28860029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanocytic "ball-in-mitts" and "microalveolar structures" and their role in the development of cellular blue nevi.
    Kazakov DV; Michal M
    Ann Diagn Pathol; 2007 Jun; 11(3):160-75. PubMed ID: 17498590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compound melanocytic nevi with granular cell changes.
    El-Gamal HM; Robinson-Bostom L; Saddler KD; Pan T; Mihm MC
    J Am Acad Dermatol; 2004 May; 50(5):765-6. PubMed ID: 15097962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined nevi of the conjunctiva.
    Crawford JB; Howes EL; Char DH
    Trans Am Ophthalmol Soc; 1999; 97():170-83; discussion 183-5. PubMed ID: 10703123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined nevi of the conjunctiva.
    Crawford JB; Howes EL; Char DH
    Arch Ophthalmol; 1999 Sep; 117(9):1121-7. PubMed ID: 10496382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinctive eosinophilic cytoplasmic inclusion bodies in melanocytic nevi: an immunohistochemical and ultrastructural study.
    Shon W; Wada DA; Gibson LE; Flotte TJ; Scheithauer BW
    J Cutan Pathol; 2011 Nov; 38(11):865-70. PubMed ID: 21819442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjunctival Melanocytic Nevi With Granular Cell Change.
    Eiger-Moscovich M; Eagle RC; Lally SE; Shields CL; Shields JA; Langer PD; Sheehan J; Milman T
    Arch Pathol Lab Med; 2020 Apr; 144(4):457-465. PubMed ID: 31469587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
    Hitzer S; Bialasiewicz AA; Richard G
    Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Triggered trap": nevoid malignant melanoma.
    McNutt NS
    Semin Diagn Pathol; 1998 Aug; 15(3):203-9. PubMed ID: 9711670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunohistopathological study of conjunctival melanocytic lesions in pediatric and adolescent patients. A case series.
    Bogdănici CM; Costea CF; Dumitrescu GF; Sava A; Ciobanu Apostol DG; Scripcariu DV; Nicoară SD; Tănase DM; Andriescu EC; Cărăuleanu A; Danciu M; Sălăvăstru SC; Schmitzer S; Cucu AI; Niagu IA
    Rom J Morphol Embryol; 2021; 62(4):907-915. PubMed ID: 35673810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pigmented conjunctival growing lesion in a teenager: nevus or melanoma?
    Burgués-Ceballos A; Saornil MA; García-Alvarez C; Lagarto EG
    Can J Ophthalmol; 2013 Dec; 48(6):e154-6. PubMed ID: 24314430
    [No Abstract]   [Full Text] [Related]  

  • 39. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation.
    Hoang MP; Prieto VG; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Sep; 28(8):400-6. PubMed ID: 11493377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.